Ibio Inc IBIO:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/03/24 EDT
1.95quote price arrow down-0.04 (-1.91%)
Volume
491
Close
1.99quote price arrow down-0.04 (-1.97%)
Volume
170,640
52 week range
1.02 - 22.60
Loading...
  • Open2.03
  • Day High2.15
  • Day Low1.95
  • Prev Close2.03
  • 52 Week High22.60
  • 52 Week High Date05/03/23
  • 52 Week Low1.02
  • 52 Week Low Date01/18/24

Key Stats

  • Market Cap17.137M
  • Shares Out8.61M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta-3.44
  • YTD % Change45.26

KEY STATS

  • Open2.03
  • Day High2.15
  • Day Low1.95
  • Prev Close2.03
  • 52 Week High22.60
  • 52 Week High Date05/03/23
  • 52 Week Low1.02
  • 52 Week Low Date01/18/24
  • Market Cap17.137M
  • Shares Out8.61M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta-3.44
  • YTD % Change45.26

RATIOS/PROFITABILITY

  • EPS (TTM)-21.91
  • P/E (TTM)-0.09
  • Fwd P/E (NTM)-1.43
  • EBITDA (TTM)-19.826M
  • ROE (TTM)-148.27%
  • Revenue (TTM)50,000.001
  • Gross Margin (TTM)75.41%
  • Net Margin (TTM)-41,546.00%
  • Debt To Equity (MRQ)146.44%

EVENTS

  • Earnings Date05/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ibio Inc

 

Content From Our Affiliates

Profile

MORE
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu technology is an AI-based tool designed to predict a library of antibodies with...
William Clark
Independent Chairman of the Board
Martin Brenner Ph.D.
Chief Executive Officer, Chief Scientific Officer
Felipe Duran
Chief Financial Officer
Address
8800 HSC Pkwy
Bryan, TX
77807
United States

Top Peers

SYMBOLLASTCHG%CHG
AKTX
Akari Therapeutics PLC
1.36-0.11-7.48%
GOVX
GeoVax Labs Inc
1.59+0.17+11.97%
HEPA
Hepion Pharmaceuticals Inc
1.47-0.05-3.29%
TOVX
Theriva Biologics Inc
0.403-0.015-3.5885%
ENVB
Enveric Biosciences Inc
0.98+0.0545+5.8887%